Hosted on MSN
TOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growth
CEO Daniel Virnich highlighted a strong start to the year, reporting "revenue for Q1 increased by 10% versus the prior year period," mainly driven by robust performance in the retail Pharmacy and ...
(RTTNews) - The Oncology Institute, Inc. (TOI), reported its financial results for the first quarter of 2025 and reaffirms the full year guidance. The company operates a value-based care model focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results